Evgeny Edovitsky

841 total citations
7 papers, 736 citations indexed

About

Evgeny Edovitsky is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Evgeny Edovitsky has authored 7 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cell Biology, 6 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Evgeny Edovitsky's work include Proteoglycans and glycosaminoglycans research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell Adhesion Molecules Research (2 papers). Evgeny Edovitsky is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell Adhesion Molecules Research (2 papers). Evgeny Edovitsky collaborates with scholars based in Israel and United States. Evgeny Edovitsky's co-authors include Israël Vlodavsky, Eyal Zcharia, Michael Elkin, Tamar Peretz, Neta Ilan, Yulia Bashenko, Flonia Levy‐Adam, Anna Zetser, Immanuel Lerner and Eli Pikarsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Evgeny Edovitsky

7 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evgeny Edovitsky Israel 7 591 569 110 92 80 7 736
M Bar-Ner United States 9 428 0.7× 429 0.8× 111 1.0× 96 1.0× 83 1.0× 11 626
Ilanit Boyango Israel 11 417 0.7× 407 0.7× 86 0.8× 31 0.3× 84 1.1× 16 582
J. Kevin Langford United States 7 480 0.8× 477 0.8× 163 1.5× 156 1.7× 170 2.1× 12 826
Lilach Gutter-Kapon Israel 6 240 0.4× 305 0.5× 54 0.5× 29 0.3× 139 1.7× 6 477
Guido David Belgium 7 267 0.5× 257 0.5× 64 0.6× 29 0.3× 67 0.8× 10 429
So-I Shin Japan 9 121 0.2× 610 1.1× 80 0.7× 68 0.7× 262 3.3× 16 785
Durwin Tsay United States 7 169 0.3× 309 0.5× 36 0.3× 37 0.4× 89 1.1× 7 571
Kate M. Moore United Kingdom 8 298 0.5× 262 0.5× 45 0.4× 115 1.3× 101 1.3× 11 535
Kei Matsuda United States 7 226 0.4× 478 0.8× 148 1.3× 12 0.1× 305 3.8× 13 687
Helicia Paz United States 10 84 0.1× 308 0.5× 79 0.7× 41 0.4× 117 1.5× 12 463

Countries citing papers authored by Evgeny Edovitsky

Since Specialization
Citations

This map shows the geographic impact of Evgeny Edovitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeny Edovitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeny Edovitsky more than expected).

Fields of papers citing papers by Evgeny Edovitsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeny Edovitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeny Edovitsky. The network helps show where Evgeny Edovitsky may publish in the future.

Co-authorship network of co-authors of Evgeny Edovitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Evgeny Edovitsky. A scholar is included among the top collaborators of Evgeny Edovitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgeny Edovitsky. Evgeny Edovitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Nasser, Nicola J., Aaron Avivi, Itay Shafat, et al.. (2009). Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis. Proceedings of the National Academy of Sciences. 106(7). 2253–2258. 46 indexed citations
2.
Lerner, Immanuel, Eli Pikarsky, Amichay Meirovitz, et al.. (2008). Function of Heparanase in Prostate Tumorigenesis: Potential for Therapy. Clinical Cancer Research. 14(3). 668–676. 62 indexed citations
3.
Zetser, Anna, Yulia Bashenko, Evgeny Edovitsky, et al.. (2006). Heparanase Induces Vascular Endothelial Growth Factor Expression: Correlation with p38 Phosphorylation Levels and Src Activation. Cancer Research. 66(3). 1455–1463. 208 indexed citations
4.
Benhamron, Sandrine, Hovav Nechushtan, Inna Verbovetski, et al.. (2006). Translocation of Active Heparanase to Cell Surface Regulates Degradation of Extracellular Matrix Heparan Sulfate upon Transmigration of Mature Monocyte-Derived Dendritic Cells. The Journal of Immunology. 176(11). 6417–6424. 47 indexed citations
5.
Edovitsky, Evgeny, Immanuel Lerner, Eyal Zcharia, et al.. (2005). Role of endothelial heparanase in delayed-type hypersensitivity. Blood. 107(9). 3609–3616. 126 indexed citations
6.
Zcharia, Eyal, Deborah Philp, Evgeny Edovitsky, et al.. (2005). Heparanase Regulates Murine Hair Growth. American Journal Of Pathology. 166(4). 999–1008. 44 indexed citations
7.
Edovitsky, Evgeny, Michael Elkin, Eyal Zcharia, Tamar Peretz, & Israël Vlodavsky. (2004). Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis. JNCI Journal of the National Cancer Institute. 96(16). 1219–1230. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026